Tribeca Lifts Integral Diagnostics Stake Above 6% as CEO Adds Shares
IDX: $1.76 -0.28% · MC: $622M
Tribeca Investment Partners’ reported voting power in Integral Diagnostics rose from 5.03% to 6.04%, while CEO Jason Martinez acquired additional shares on market, increasing his direct holding from 30,000 to 45,000 shares. The substantial-holder notice lists on-market purchases and sales since its previous filing, but the supplied excerpt does not include the full transaction schedule.

Comments